Literature DB >> 19058925

The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.

V Anna Gyarmathy1, Alan Neaigus, Mary M Mitchell, Eszter Ujhelyi.   

Abstract

We assessed whether syringe type, syringe cleaning and distributive syringe sharing were associated with self-reported and laboratory-confirmed HCV infection among Hungarian IDUs. Injecting drug users (N=215) were recruited from non-treatment settings in Budapest, Hungary between October 2005 and December 2006. Multivariate logistic regression models identified correlates of self-report of being HCV infected and testing positive for HCV. While 37% tested positive for HCV, 14% of the total (39% of those who tested positive) self-reported being HCV infected. Using any two-piece syringes was significantly associated with self-reported HCV infection, while distributive syringe sharing was not associated with self-report of being HCV infected. Engaging in receptive sharing of only one-piece syringes but always cleaning before reuse was not associated with testing HCV positive, while any receptive sharing of only one-piece syringes and not always cleaning before reuse was significantly associated with testing HCV positive. Sharing cookers and squirting drugs from one syringe into another syringe were not associated with testing HCV positive. The high percent of those HCV infected who did not know they were infected highlights the need to provide better access to confidential testing and counseling services. Counseling should emphasize secondary prevention of HCV among HCV infected IDUs. Our findings also indicate that syringe type and syringe cleaning practices may play a role in HCV transmission. Ethnographic research should identify the reasons why IDUs may use two-piece syringes and suggest means to reduce their use. Thorough cleaning of one-piece syringes when sterile syringes are unavailable may be an efficient way to reduce the risk of HCV infection.

Entities:  

Mesh:

Year:  2008        PMID: 19058925      PMCID: PMC2628960          DOI: 10.1016/j.drugalcdep.2008.10.014

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  31 in total

1.  HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1.

Authors:  M C Clatts; R Heimer; N Abdala; L A Goldsamt; J L Sotheran; K T Anderson; T M Gallo; L D Hoffer; P A Luciano; T Kyriakides
Journal:  J Acquir Immune Defic Syndr       Date:  1999-10-01       Impact factor: 3.731

2.  Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.

Authors:  V Anna Gyarmathy; Alan Neaigus; Maureen Miller; Samuel R Friedman; Don C Des Jarlais
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

3.  Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?

Authors:  Farzana Kapadia; David Vlahov; Don C Des Jarlais; Steffanie A Strathdee; Lawrence Ouellet; Peter Kerndt; Edward V Morse E; Ian Williams; Richard S Garfein
Journal:  Epidemiology       Date:  2002-11       Impact factor: 4.822

4.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

5.  Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.

Authors:  Danielle C Ompad; Crystal M Fuller; David Vlahov; David Thomas; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079

6.  Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions.

Authors:  Nadia Abdala; Michelle Crowe; Yanis Tolstov; Robert Heimer
Journal:  Subst Use Misuse       Date:  2004-03       Impact factor: 2.164

7.  "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

8.  Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs.

Authors:  M D Gaughwin; E Gowans; R Ali; C Burrell
Journal:  AIDS       Date:  1991-08       Impact factor: 4.177

9.  The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.

Authors:  V Anna Gyarmathy; József Rácz; Alan Neaigus; Eszter Ujhelyi
Journal:  AIDS Educ Prev       Date:  2004-06

10.  Syringe type and drug injector risk for HIV infection: a case study in Texas.

Authors:  William A Zule; David P Desmond; James Alan Neff
Journal:  Soc Sci Med       Date:  2002-10       Impact factor: 4.634

View more
  11 in total

1.  The association between social marginalisation and the injecting of alcohol amongst IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  Int J Drug Policy       Date:  2011-07-20

2.  Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus.

Authors:  V Anna Gyarmathy; Alan Neaigus; Nan Li; Eszter Ujhelyi; Irma Caplinskiene; Saulius Caplinskas; Carl A Latkin
Journal:  Scand J Infect Dis       Date:  2010-09-15

3.  Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; M Raza Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Drug Policy       Date:  2010-12-10

4.  Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs.

Authors:  Christine U Oramasionwu; Terence L Johnson; William A Zule; Jessica Carda-Auten; Carol E Golin
Journal:  Am J Public Health       Date:  2015-04-16       Impact factor: 9.308

5.  Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.

Authors:  Adam Trickey; Margaret T May; Vivian Hope; Zoe Ward; Monica Desai; Ellen Heinsbroek; Matthew Hickman; Peter Vickerman
Journal:  Drug Alcohol Depend       Date:  2018-09-15       Impact factor: 4.492

6.  Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England.

Authors:  Joanna M Kesten; Rachel Ayres; Jane Neale; Jody Clark; Peter Vickerman; Matthew Hickman; Sabi Redwood
Journal:  Int J Drug Policy       Date:  2016-10-24

7.  Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania.

Authors:  V Anna Gyarmathy; Alan Neaigus; Nan Li; Eszter Ujhelyi; Irma Caplinskiene; Saulius Caplinskas; Carl A Latkin
Journal:  Eur Addict Res       Date:  2010-08-26       Impact factor: 3.015

8.  A needle in the haystack--the dire straits of needle exchange in Hungary.

Authors:  V Anna Gyarmathy; Róbert Csák; Katalin Bálint; Eszter Bene; András Ernő Varga; Mónika Varga; Nóra Csiszér; István Vingender; József Rácz
Journal:  BMC Public Health       Date:  2016-02-16       Impact factor: 3.295

9.  Options for reducing HIV transmission related to the dead space in needles and syringes.

Authors:  William A Zule; Poonam G Pande; David Otiashvili; Georgiy V Bobashev; Samuel R Friedman; V Anna Gyarmathy; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2018-01-15

10.  Prevalence of hepatitis C viral infection among injecting drug users in a Saudi Arabian hospital: A point cross sectional survey.

Authors:  Osama A Alibrahim; Yusuf A Misau; Alkali Mohammed; Mohammad Bashir Faruk; Izzeldin Ss
Journal:  J Public Health Afr       Date:  2018-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.